| 1 |
杨启文, 吴安华, 胡必杰, 等.临床重要耐药菌感染传播防控策略专家共识 [J]. 中国感染控制杂志, 2021, 20(1): 1-14.
|
| 2 |
李中美, 俞周来, 吴力, 等.神经内科重症监护室医院感染病原菌和影响因素分析 [J]. 中华医院感染学杂志, 2020, 30(5): 685-688.
|
| 3 |
DeRosier J, Stalhandske E, Bagian JP, et al. Using health care failure mode and effect analysis: the VA National Center for patient safety's prospective risk analysis system [J]. Jt Comm J Qual Improv, 2002, 28(5): 248-267.
|
| 4 |
唐映莲, 梁水英, 黄荣静, 等. 失效模式与效应分析法在心内科患者跌倒安全管理中的应用 [J]. 现代临床护理, 2019, 18(6): 55-59.
|
| 5 |
贾瑶, 梁新慧, 吴惟, 等. 医疗失效模式与效应分析在颅脑创伤急诊手术护理风险管理中的应用 [J]. 实用临床医药杂志, 2024, 28(8): 127-133.
|
| 6 |
张舒, 郑静, 刘先锋, 等. HFMEA模式在人工气道患者气囊压力管理中的应用 [J]. 中华危重病急救医学, 2023, 35(3): 269-273.
|
| 7 |
张琦, 范晓嬿. HFMEA模式在急诊行经皮冠脉介入治疗患者转运交接中的效果评价 [J]. 复旦学报 (医学版), 2021, 48(6): 783-790.
|
| 8 |
中华人民共和国卫生部. 关于印发医院感染诊断标准(试行)的通知 [EB/OL]. (2001-11-07) [2023-07-11].
|
| 9 |
Yu X, Gan T, Zhu Y, et al. Healthcare failure mode and effect analysis (HFMEA) for improving the qualification rate of disinfection quality monitoring process [J]. J Infect Public Health, 2020, 13(5): 1-6.
|
| 10 |
Pogorzelska-Maziarz M, Nembhard IM, Schnall R, et al.Psychome-tric evaluation of an instrument for measuring organizational climate for quality: evidence from a national sample of infection preventionists [J]. Am J Med Qual, 2016, 31(5): 441-447.
|
| 11 |
李淑花, 商临萍, 袁丽荣, 等. 感染预防控制文化量表的汉化及信效度检验 [J]. 中华护理杂志, 2024, 59(6): 713-718.
|
| 12 |
张继芝, 张伟, 徐玉芝, 等. 医疗失效模式与效应分析在住院患者口服给药风险管理中的应用 [J]. 齐鲁护理杂志, 2019, 5(16): 53-55.
|
| 13 |
林露, 张菊, 李刚, 等. 失效模式与效应分析联合PDCA循环在重症监护病房多重耐药菌院内感染防控中的应用 [J]. 华西医学, 2022, 37(3): 363-368.
|
| 14 |
Wang X, Du ZY, Huang WC, et al. Outbreak of multidrug-re- sistant Acinetobacter baumanni ST208 producing OXA-23- like carbapenemase in a children's hospital in Shanghai, China [J]. Microb Drug Resist, 2021, 27(6): 816-822.
|
| 15 |
邓春蕾, 彭娜, 马廉亭, 等. 标准化护理在神经外科监护室多重耐药菌感染管理中的应用效果 [J]. 中国临床神经外科杂志, 2020, 25(5): 321-323.
|
| 16 |
单荣芳, 姜萍, 严红燕, 等. 神经外科ICU患者多重耐药菌感染危险因素及其与TLR4基因多态性的关联 [J]. 中华医院感染学杂志, 2023, 33(13): 1981-1985.
|
| 17 |
World Health Organization. Guidelines for the prevention and control of carbapenem-resistant organisms, 2022[EB/OL]. [2023-05-01].
|
| 18 |
黄勋, 邓子德, 倪语星, 等. 多重耐药菌医院感染预防与控制中国专家共识 [J]. 中国感染控制杂志, 2015, 14(1): 1-8.
|
| 19 |
梁江淑渊, 曾妃. ICU高频接触物体表面多重耐药菌感染及控制的研究进展[J]. 护理研究, 2020, 34(11): 1930-1934.
|
| 20 |
Costa DM, Johani K, Melo DS, et al. Biofilm contamination of high-touched surfaces in intensive care units: Epidemiology and potential impacts [J]. Lett Appl Microbiol, 2019, 68: 269-276.
|
| 21 |
Centers for Disease Control and Prevention. CDC's Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for environmental infection control in healthcare facilities, 2021 [EB/OL]. [2023-05-01].
|
| 22 |
Anderson DJ, Chen LF, Weber DJ, et al. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study [J]. Lancet, 2017, 389(10071): 805-814.
|
| 23 |
王明贵. 广泛耐药革兰阴性菌感染的实验诊断、抗菌治疗及医院感染控制: 中国专家共识 [J]. 中国感染与化疗杂志, 2017, 17(1): 82-93.
|
| 24 |
Smith BA, Jones CD, Brown EF, et al.Augmented reality training improves multidrug-resistant organism transmission prevention by mobile healthcare workers [J]. Am J Infect Control, 2023, 51(6): 689-695.
|
| 25 |
De Bono S, Heling G, Borg MA. Organizational culture and its implications for infection prevention and control in healthcare institutions [J]. J Hosp Infect, 2014, 86(1): 1-6.
|
| 26 |
王鹏, 丁丽丽, 唐玲, 等. 举办感染控制文化宣传周对提升医务人员感控理念的效果评价 [J]. 中华医院感染学杂志, 2018, 28(8): 1253-1256.
|